Abstract | BACKGROUND/AIM: MATERIALS AND METHODS: These cell lines were stimulated with 10 to 20 μM fucoxanthin and/or fucoxanthinol, followed by cell viability assays, Annexin V immunofluorescence to evaluate apoptosis, as well as mRNA and protein extractions for changes in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) members' expressions and nuclear translocations. RESULTS:
Fucoxanthin and fucoxanthinol reduced the viability of MCF-7 and MDA-MB-231 cells in a time-dependent manner as a result of increased apoptosis. In both cell lines, modulatory actions of fucoxanthinol on members of the NF-κB pathway were more pronounced than that of fucoxanthin. CONCLUSION:
|
Authors | Arlette Rwigemera, Jean Mamelona, Luc J Martin |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 1
Pg. 207-19
(Jan 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 25550553
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- NF-kappa B
- SOX9 Transcription Factor
- SOX9 protein, human
- Xanthophylls
- beta Carotene
- fucoxanthin
- fucoxanthinol
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Apoptosis Regulatory Proteins
(metabolism)
- Breast Neoplasms
- Cell Nucleus
(metabolism)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Drug Screening Assays, Antitumor
- Female
- Gene Expression
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- MCF-7 Cells
- NF-kappa B
(genetics, metabolism)
- SOX9 Transcription Factor
(genetics, metabolism)
- Xanthophylls
(pharmacology)
- beta Carotene
(analogs & derivatives, pharmacology)
|